Implant Loads, Quarantine and Early Release

Implant Fundamentals, Packaging, and Assembly

Under Food and Drug Administration (FDA) regulations, an implant is generally defined as a device placed into a surgically or naturally formed body cavity and intended to remain there for at least 30 days. While the FDA generally relies on this 30-day benchmark, the agency may also designate a device intended for a shorter duration as an implant. In the human body, implanted materials present a unique clinical vulnerability. Local host defense mechanisms are naturally compromised around foreign materials. Furthermore, microorganisms can readily adhere to the foreign surfaces of an implanted device and prove exceptionally difficult to eliminate. Because an implant significantly increases both the risk and the severity of surgical site infections, the sterile processing technician's role in processing these items demands meticulous care.

Preparing implants begins with thorough decontamination, inspection, and assembly according to device manufacturers' instructions for use (IFU) and facility policy. Technicians must inspect every implant component for cleanliness, structural integrity, and correct count prior to packaging. When assembling multi-level implant trays, items must be arranged to ensure direct sterilant contact with all surfaces and uninhibited condensate drainage. Technicians must also verify that trays do not exceed the manufacturer-validated weight limit; 25 pounds (11.3 kg), including the container and its contents, is a commonly cited upper limit. Heavy orthopedic implant trays may also require extended sterilization exposure or dry times based on validated manufacturer instructions.

Packaging materials selected for implant loads must allow adequate sterilant penetration during the cycle and maintain a protective sterile barrier until the point of use. If rigid containers are utilized, technicians must inspect the container bodies, filters, gaskets, closures, and other required components for integrity before sterilization. Tamper-evident devices must then be applied as directed by the container manufacturer's instructions. After sterilization, handling warm implant packages before they reach ambient room temperature can cause microbial wicking and package contamination. To prevent condensate formation and protect sterility, implant loads must cool completely in a designated area free from drafts and air conditioning vents.